Ypke van Oosterhout PhD | CEO
Ypke van Oosterhout (1964) is the pioneering scientist/researcher behind T-Guard’s development, and the founder of Xenikos. His in-depth knowledge, hands-on experience and proven commitment to development of the medicine are unparalleled.
Maarten Frijlink MSc | COO
Maarten Frijlink is a core member of Xenikos’ management team. His background, covering 25 years of industrial experience in a broad range of managerial roles, is key to the commercial development of T-Guard™.
Maarten’s track record includes a variety of leading roles, is key to the commercial development of T-Guard™.
Eric van Hooren | Chief Development Officer
Eric van Hooren has over 20 years of experience in the pharmaceutical industry. He has a broad background in strategic drug development for both new biological and new chemical entities, as well as in global clinical trial management and medical marketing. Prior to joining Xenikos, Eric was Director Clinical Operations at Acerta-Pharma, where he was responsible...
Stephan Winckels MD PhD | Medical Monitor
Stephan Winckels has extensive experience in clinical oncology drug development. Trained as a medical doctor at Maastricht University, he obtained his PhD in Medical Physiology from Utrecht University. Stephan started his career in the pharmaceutical industry in 2009 as a Medical Monitor at Wyeth (now Pfizer). Later, he took over project management responsibilities...
Suzanne Vink-Hermeling | Manager QA and QP
Suzanne Vink-Hermeling studied pharmacy at Utrecht University. She started her PhD at the same University at the department of Pharmaceutics and at the department of animal laboratory facility. Her PhD focused on the unwanted immunogenicity of therapeutic proteins. In 2005 she started at OctoPlus first as a project manager and scientist formulation development.
André de Lege | CFO
André de Lege is chartered accountant, hands-on finance professional, with over 20 years broad expertise (including tax, grants & legal). He has supported different high-tech start-up companies, and served as CFO of an international contract lab/medical device contract manufacture, in which role he was amongst others responsible for financial (IFRS) reports, cash flow forecasts...